STAR

Strides Pharma Science Share Price

 

 

Strides Pharma Science live price: ₹1000. It opened at ₹996 vs previous close ₹996; intraday high/low: ₹1,011/₹996. The 50 & 200 DMA stand at ₹910.87/₹880.54.

Strides Pharma Science Performance

  • Today's Low
  • ₹996
  • Today's High
  • ₹1,011
  • 52 Week Low
  • ₹597
  • 52 Week High
  • ₹1,025
  • Open Price₹996
  • Previous Close₹996
  • Volume210,769
  • 50 DMA₹910.87
  • 100 DMA₹895.31
  • 200 DMA₹880.54

Investment Returns

  • Over 1 Month + 14.56%
  • Over 3 Month + 6.17%
  • Over 6 Month + 17.53%
  • Over 1 Year + 71.12%

Smart Investing Starts Here Start SIP with Strides Pharma Science for Steady Growth!

Invest Now

Strides Pharma Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 9,217
  • P/B Ratio
  • 3.1
  • Average True Range
  • 34.21
  • EPS
  • 59.78
  • Dividend Yield
  • 0.4
  • MACD Signal
  • 23.55
  • RSI
  • 68.9
  • MFI
  • 69.82

Strides Pharma Science Financials

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹1,000.00
+ 3.75 (0.38%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹942.32
  • 50 Day
  • ₹910.87
  • 100 Day
  • ₹895.31
  • 200 Day
  • ₹880.54

Resistance and Support

1002.27 Pivot Speed
  • R3 1,023.63
  • R2 1,017.27
  • R1 1,008.63
  • S1 993.63
  • S2 987.27
  • S3 978.63

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic drugs. It focuses on niche therapeutic segments, including anti-retrovirals, oncology, and central nervous system, serving markets worldwide.

Strides Pharma Science has an operating revenue of Rs. 4,725.61 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 140% is exceptional. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 12% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 2% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 34 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of A is the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Strides Pharma Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-30 Quarterly Results
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-01-30 Quarterly Results
Date Purpose Remarks
2025-07-22 FINAL Rs.4.00 per share(40%)Final Dividend
2024-09-09 FINAL Rs.2.50 per share(25%)Final Dividend
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend
View Strides Pharma Science Dividend History Arrow

Strides Pharma Science F&O

Strides Pharma Science Shareholding Pattern

27.86%
8.59%
3.05%
29.52%
0.01%
21.41%
9.56%

Strides Pharma Science FAQs

Strides Pharma Science share price is ₹1,000 As on 11 April, 2026 | 10:42

The Market Cap of Strides Pharma Science is ₹9217.3 Cr As on 11 April, 2026 | 10:42

The P/E ratio of Strides Pharma Science is 18 As on 11 April, 2026 | 10:42

The PB ratio of Strides Pharma Science is 3.1 As on 11 April, 2026 | 10:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23